Adjuvant Docetaxel for Node-Positive Breast Cancer

Miguel Martín, Tadeusz Pieńkowski, John R. Mackey, Marek Pawlicki, Jean‐Paul Guastalla, Charles H. Weaver, Eva Tomiak, Taher Al‐Tweigeri, Linnea Chap, É Juhos, R. Guévin, Anthony Howell, Tommy� Fornander, John D. Hainsworth, Robert E. Coleman, J. Vinholes, Manuel Modiano, Tamás Pintér, Shou Ching Tang, Bruce Colwell, Catherine Prady, Louise Provencher, David Walde, Álvaro Rodríguez-Lescure, Judith Hugh, Camille Loret, Matthieu Rupin, Sandra Blitz, Philip Jacobs, M Murawsky, A. Riva, Charles L. Vogel

New England Journal of Medicine, 2005

Hospital Clínico San Carlos, The Maria Sklodowska-Curie National Research Institute of Oncology, Centre Léon Bérard, Regional Cancer Center, Ottawa Regional Cancer Foundation, Saskatchewan Cancer Agency, National Institute of Oncology, Hôpital Saint-Luc, The Christie Hospital, Stockholm South General Hospital, Sarah Cannon, Weston Park Cancer Centre, Arizona Research Center, Petz Aladár Megyei Oktató Kórház, Nova Scotia Cancer Centre, Dr. Georges-L.-Dumont University Hospital Centre, Hôpital du Saint-Sacrement, Sault Area Hospital, Hospital General Universitario de Elche, Institute of Health Economics

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

951

Citations

View on Google Scholar

Adjuvant Docetaxel for Node-Positive Breast Cancer

Abstract

Journal Details

Join JournalsHub

Welcome Back